Reach the editor
For editorial enquiries, corrections, or coverage requests, email the desk directly:
We read every message. Please note we cannot provide personalised investment advice — all coverage is educational and general in nature.
Contact
OtimoInvest is an independent, single-desk biotech research publication. Coverage is produced and reviewed editorially, drawing on public filings, primary news sources and company disclosures. We welcome corrections, questions about methodology, and suggestions for companies or programs worth covering.
Educational purposes only. Not financial advice.